Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SYNCOM FORMULATIONS vs INDOCO REMEDIES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SYNCOM FORMULATIONS INDOCO REMEDIES SYNCOM FORMULATIONS/
INDOCO REMEDIES
 
P/E (TTM) x 40.1 30.0 133.6% View Chart
P/BV x 4.1 2.9 140.4% View Chart
Dividend Yield % 0.0 0.7 -  

Financials

 SYNCOM FORMULATIONS   INDOCO REMEDIES
EQUITY SHARE DATA
    SYNCOM FORMULATIONS
Mar-23
INDOCO REMEDIES
Mar-23
SYNCOM FORMULATIONS/
INDOCO REMEDIES
5-Yr Chart
Click to enlarge
High Rs13423 3.1%   
Low Rs5308 1.5%   
Sales per share (Unadj.) Rs2.4181.1 1.3%  
Earnings per share (Unadj.) Rs0.215.4 1.4%  
Cash flow per share (Unadj.) Rs0.323.1 1.1%  
Dividends per share (Unadj.) Rs02.25 0.0%  
Avg Dividend yield %00.6 0.0%  
Book value per share (Unadj.) Rs2.7111.5 2.4%  
Shares outstanding (eoy) m940.0092.15 1,020.1%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.72.0 182.2%   
Avg P/E ratio x41.123.7 173.6%  
P/CF ratio (eoy) x33.515.8 211.8%  
Price / Book Value ratio x3.23.3 98.3%  
Dividend payout %014.6 0.0%   
Avg Mkt Cap Rs m8,24933,683 24.5%   
No. of employees `000NANA-   
Total wages/salary Rs m2443,226 7.6%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m2,24316,686 13.4%  
Other income Rs m14624 612.4%   
Total revenues Rs m2,38916,710 14.3%   
Gross profit Rs m1992,860 7.0%  
Depreciation Rs m45706 6.4%   
Interest Rs m34250 13.6%   
Profit before tax Rs m2661,928 13.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m65505 12.9%   
Profit after tax Rs m2011,423 14.1%  
Gross profit margin %8.917.1 51.8%  
Effective tax rate %24.526.2 93.3%   
Net profit margin %8.98.5 105.0%  
BALANCE SHEET DATA
Current assets Rs m1,8178,082 22.5%   
Current liabilities Rs m1,1324,245 26.7%   
Net working cap to sales %30.623.0 132.9%  
Current ratio x1.61.9 84.3%  
Inventory Days Days23125 922.0%  
Debtors Days Days1,229768 160.1%  
Net fixed assets Rs m1,9619,055 21.7%   
Share capital Rs m940184 510.0%   
"Free" reserves Rs m1,62010,092 16.1%   
Net worth Rs m2,56010,276 24.9%   
Long term debt Rs m01,435 0.0%   
Total assets Rs m3,77817,137 22.0%  
Interest coverage x8.88.7 101.3%   
Debt to equity ratio x00.1 0.0%  
Sales to assets ratio x0.61.0 61.0%   
Return on assets %6.29.8 63.6%  
Return on equity %7.813.8 56.6%  
Return on capital %11.718.6 62.9%  
Exports to sales %63.347.5 133.3%   
Imports to sales %7.711.5 66.8%   
Exports (fob) Rs m1,4197,919 17.9%   
Imports (cif) Rs m1721,917 9.0%   
Fx inflow Rs m1,4197,919 17.9%   
Fx outflow Rs m2041,917 10.7%   
Net fx Rs m1,2156,002 20.2%   
CASH FLOW
From Operations Rs m1051,788 5.9%  
From Investments Rs m-450-2,082 21.6%  
From Financial Activity Rs m350228 153.5%  
Net Cashflow Rs m6-65 -8.9%  

Share Holding

Indian Promoters % 50.6 58.7 86.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 21.3 -  
FIIs % 0.0 1.7 -  
ADR/GDR % 0.0 0.0 -  
Free float % 49.4 41.3 119.8%  
Shareholders   289,982 32,600 889.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SYNCOM FORMULATIONS With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on SYNCOM FORMULATIONS vs Indoco Remedies

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

SYNCOM FORMULATIONS vs Indoco Remedies Share Price Performance

Period SYNCOM FORMULATIONS Indoco Remedies S&P BSE HEALTHCARE
1-Day 1.72% -1.82% 1.18%
1-Month -20.54% -6.45% -0.75%
1-Year 125.65% 1.09% 61.82%
3-Year CAGR 53.72% 4.71% 18.16%
5-Year CAGR 59.23% 11.97% 19.79%

* Compound Annual Growth Rate

Here are more details on the SYNCOM FORMULATIONS share price and the Indoco Remedies share price.

Moving on to shareholding structures...

The promoters of SYNCOM FORMULATIONS hold a 50.6% stake in the company. In case of Indoco Remedies the stake stands at 58.7%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of SYNCOM FORMULATIONS and the shareholding pattern of Indoco Remedies.

Finally, a word on dividends...

In the most recent financial year, SYNCOM FORMULATIONS paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.

Indoco Remedies paid Rs 2.3, and its dividend payout ratio stood at 14.6%.

You may visit here to review the dividend history of SYNCOM FORMULATIONS, and the dividend history of Indoco Remedies.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 550 Points| Nifty Tops 22,250 | Power Stocks Shine Sensex Today Rallies 550 Points| Nifty Tops 22,250 | Power Stocks Shine(10:30 am)

Asian markets traded lower, while the US stock indices ended higher overnight with the S&P 500 hitting a record closing high ahead of key economic data.